drugset / Trial / NCT07096583
An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer
Phase 1/2
Active not recruiting
20 enrolled
Anhui Provincial Cancer Hospital
Anhui Kecheng intelligent health technology Co., LTD · collab
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the remission effect and safety of intravenous injection of METR-NK cells as adjuvant therapy on bone marrow suppression in patients with ovarian cancer after chemotherapy
Timeline
- Start
- 2025-07-07
- Primary completion
- 2026-07-30
- Completion
- 2027-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | METR-NK cell | Unknown | 2e+07 cells/kg | Intravenous |